⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | HDFC Business Cycle Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | HDFC MF | HDFC MF |
| Category | Equity - Thematic Fund - Other | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹15.18 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★ | ★★★★★ |
| Benchmark | NIFTY 500 - TRI | BSE Health Care - TRI |
| Fund Manager | Rahul Baijal | Nikhil Mathur |
| Inception | 30 Nov 2022 | 04 Oct 2023 |
| Returns | ||
| 1Y | -3.20% | 22.64% |
| 3Y | 11.00% | 30.41% |
| 5Y | — | — |
| Since Inception | 11.41% | 29.15% |
| Risk | ||
| 14.18 | 14.07 | |
| 0.97 | 0.59 | |
| 0.34 | 1.59 | |
| 1.11 | 21.67 | |
| 0.62 | 3.48 | |
| -12.69% | -9.23% | |
| Costs | ||
| Expense Ratio | 1.14% | 1.03% |
| Exit Load | 1% on or before 1Y, Nil after 1Y | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹100 | ₹100 |
| Min Lumpsum | ₹100 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
HDFC MF92%
HDFC MF92%
7.8%Only 7.8% of holdings by weight are common between HDFC MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingHDFC MFHDFC MF
TREPS - Tri-party Repo10.92%4.67%
Anthem Biosciences Ltd.3.78%3.17%
Category context: Equity vs Equity. Open the full Screener →